Toggle light / dark theme

Check out the internal Google film, “The Selfish Ledger”. This probably wasn’t meant to slip onto a public web server, and so I have embedded a backup copy below. Ping me if it disappears. I will locate a permanent URL.

This 8½ minute video is a lot deeper—and possibly more insipid—than it appears. Nick Foster may be the Anti-Christ, or perhaps the most brilliant sociologist of modern times. It depends on your vantage point, and your belief in the potential of user controls and cat-in-bag containment.

He talks of a species propelling itself toward “desirable goals” by cataloging, data mining, and analyzing the past behavior of peers and ancestors—and then using that data to improve the experience of each user’s future and perhaps even their future generations. But, is he referring to shared goals across cultures, sexes and incomes? Who controls the algorithms and the goal filters?! Is Google the judge, arbiter and God?

Consider these quotes from the video. Do they disturb you? The last one sends a chill down my spine. But, I may be overreacting to what is simply an unexplored frontier. The next generation in AI. I cannot readily determine if it ushers in an era of good or bad:

  • Behavioral sequencing « a phrase used throughout the video
  • Viewing human behavior through a Lemarkian lens
  • An individual is just a carrier for the gene. The gene seeks to improve itself and not its host
  • And [at 7:25]: “The mass multigenerational examination of actions and results could introduce a model of behavioral sequencing.”

There’s that odd term again: behavioral sequencing. It suggests that we are mice and that Google can help us to act in unison toward society’s ideal goals.

Today, Fortune Magazine described it this way: “Total and absolute data collection could be used to shape the decisions you make … The ledger would essentially collect everything there is to know about you, your friends, your family, and everything else. It would then try to move you in one direction or another for your or society’s apparent benefit.”

The statements could apply just as easily to the NSA as it does to Google. At least we are entering into a bargain with Google. We hand them data and they had us numerous benefits (the same benefits that many users often overlook). Yet, clearly, this is heavy duty stuff—especially for the company that knows everything about everyone. Watch it a second time. Think carefully about the power that Google wields.

Don’t get me wrong. I may be in the minority, but I generally trust Google. I recognize that I am raw material and not a client. I accept the tradeoff that I make when I use Gmail, web search, navigate to a destination or share documents. I benefit from this bargain as Google matches my behavior with improved filtering of marketing directed at me.

But, in the back of my mind, I hope for the day that Google implements Blind Signaling and Response, so that my data can only be used in ways that were disclosed to me—and that strengthen and defend that bargain, without subjecting my behavior, relationships and predilections to hacking, misuse, or accidental disclosure.


Philip Raymond sits on Lifeboat’s New Money Systems board. He co-chairs CRYPSA, hosts the Bitcoin Event, publishes Wild Duck and is keynote speaker at global Cryptocurrency Conferences. Book a presentation or consulting engagement.

Credit for snagging this video: Vlad Savov @ TheVerge

Recently, roughly 200 eminent scientists assembled in Boston. Their agenda? Creating “superhero” human cells impervious to all viral attacks and possibly other killers—radiation, freezing, aging, or even cancer.

The trick isn’t super-soldier serum. Instead, the team is relying on tools from synthetic biology to read the cell’s genetic blueprint and rewrite large chunks of the genome to unlock these superpowers.

“There is very strong reason to believe that we can produce cells that would be completely resistant to all known viruses,” said Dr. Jef Boeke, a geneticist at New York University and a co-leader of the project. “It should also be possible to engineer other traits, including resistance to prions and cancer.”

Read more

May 15 (UPI) — Until now, scientists weren’t sure how gene activation mechanisms avoided nucleosomes, the bodyguards tasked with keeping DNA turned off.

Researchers at the University of California, San Diego, however, have pinpointed a key factor responsible for unraveling nucleosome structures and allowing genes to be activated.

Geneticists described the newly identified nucleosome destabilizing factor, or NDF, this week in the journal Genes and Development.

Read more

In the heart of San Francisco’s Mission Bay neighborhood, which not long ago was dirt lots and warehouses, Emily Leproust is cooking up what she — and $209 million worth of investor cash — believes is the future of DNA production.

Leproust is CEO of Twist Bioscience, a 5-year-old biotech company striving to make the production of synthetic DNA — which is used in fragrances, genetically modified foods and pharmaceutical drugs — cheaper, faster and smaller.

The same lab-manufactured DNA, Leproust hopes, could also transform the way data, from music to medical records, is stored.

Read more

A cure for baldness could be on the horizon after British scientists discovered that an osteoporosis drug stimulates hair growth three times quicker than other drugs.

Around four in 10 men suffer male pattern baldness by the age of 45 and two thirds by the age of 60.

At the moment only two drugs, minoxidil and finasteride, are available for the treatment of male pattern baldness (androgenetic alopecia) — the classic type of receding hair loss in men.

Read more

Crispr could eliminate Genetic disease.


It’s so small it can’t be seen with the naked eye, but research is showing that CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is bringing sight to the blind.

UC San Diego researchers are using CRISPR, a technology that allows scientists to edit genomes, to cure disease.

For the last two years, Ophthalmologist Dr. Kang Zhang and UC San Diego researchers have been working with CRISPR, injecting CRISPR into the eyes of mice to cure retinitis pigmentosa – a genetic form of blindness. “What we’ve seen in mice is that we can bring back actually 30 percent of vision sometimes even 50 percent of vision,” Dr. Zhang told NBC 7.